drugset / Trial / NCT03892330

Combination Therapy of Anthracyclines for Children With Nephroblastoma

NCT03892330

Phase 4 Not yet recruiting 120 enrolled Shengjing Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to estimate the efficacy and side effects of study drugs in children with nephroblastoma who are treated with combination therapy.

Timeline

Start
2019-06-01
Primary completion
2020-12-31
Completion
2045-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxorubicin Other / unclassified
Comparator Epirubicin Small molecule
Comparator Pirarubicin Small molecule
Background Cyclophosphamide Other / unclassified
Background Oxytetracycline Small molecule
Background Vincristine Small molecule